202 related articles for article (PubMed ID: 27482723)
41. Synthesis of oxidative metabolites of CRA13 and their analogs: Identification of CRA13 active metabolites and analogs thereof with selective CB
Hassan AHE; Cho MC; Kim HI; Yang JS; Park KT; Hwang JY; Jang CG; Park KD; Lee YS
Bioorg Med Chem; 2018 Oct; 26(18):5069-5078. PubMed ID: 30217464
[TBL] [Abstract][Full Text] [Related]
42. Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists.
Matthews JM; McNally JJ; Connolly PJ; Xia M; Zhu B; Black S; Chen C; Hou C; Liang Y; Tang Y; Macielag MJ
Bioorg Med Chem Lett; 2016 Nov; 26(21):5346-5349. PubMed ID: 27671496
[TBL] [Abstract][Full Text] [Related]
43. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
[TBL] [Abstract][Full Text] [Related]
44. 1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives: new templates among the CB1 cannabinoid receptor inverse agonists.
Muccioli GG; Wouters J; Scriba GK; Poppitz W; Poupaert JH; Lambert DM
J Med Chem; 2005 Nov; 48(23):7486-90. PubMed ID: 16279809
[TBL] [Abstract][Full Text] [Related]
45. Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.
Nasirinezhad F; Jergova S; Pearson JP; Sagen J
Neuropharmacology; 2015 Aug; 95():100-9. PubMed ID: 25486617
[TBL] [Abstract][Full Text] [Related]
46. 7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonists.
Baraldi PG; Saponaro G; Moorman AR; Romagnoli R; Preti D; Baraldi S; Ruggiero E; Varani K; Targa M; Vincenzi F; Borea PA; Aghazadeh Tabrizi M
J Med Chem; 2012 Jul; 55(14):6608-23. PubMed ID: 22738271
[TBL] [Abstract][Full Text] [Related]
47. Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor.
Janero DR; Yaddanapudi S; Zvonok N; Subramanian KV; Shukla VG; Stahl E; Zhou L; Hurst D; Wager-Miller J; Bohn LM; Reggio PH; Mackie K; Makriyannis A
ACS Chem Neurosci; 2015 Aug; 6(8):1400-10. PubMed ID: 25978068
[TBL] [Abstract][Full Text] [Related]
48. Selective CB2 receptor agonists. Part 2: Structure-activity relationship studies and optimization of proline-based compounds.
Riether D; Zindell R; Wu L; Betageri R; Jenkins JE; Khor S; Berry AK; Hickey ER; Ermann M; Albrecht C; Ceci A; Gemkow MJ; Nagaraja NV; Romig H; Sauer A; Thomson DS
Bioorg Med Chem Lett; 2015 Feb; 25(3):581-6. PubMed ID: 25556092
[TBL] [Abstract][Full Text] [Related]
49. Central glucocorticoid receptors regulate the upregulation of spinal cannabinoid-1 receptors after peripheral nerve injury in rats.
Wang S; Lim G; Mao J; Sung B; Yang L; Mao J
Pain; 2007 Sep; 131(1-2):96-105. PubMed ID: 17258396
[TBL] [Abstract][Full Text] [Related]
50. The SAR development of substituted purine derivatives as selective CB2 agonists for the treatment of chronic pain.
Guidetti R; Astles PC; Sanderson AJ; Hollinshead SP; Johnson MP; Chambers MG
Bioorg Med Chem Lett; 2014 Dec; 24(24):5572-5575. PubMed ID: 25466177
[TBL] [Abstract][Full Text] [Related]
51. Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
Vincenzi F; Targa M; Corciulo C; Tabrizi MA; Merighi S; Gessi S; Saponaro G; Baraldi PG; Borea PA; Varani K
Pain; 2013 Jun; 154(6):864-73. PubMed ID: 23518609
[TBL] [Abstract][Full Text] [Related]
52. 6-Alkoxy-5-aryl-3-pyridinecarboxamides, a new series of bioavailable cannabinoid receptor type 1 (CB1) antagonists including peripherally selective compounds.
Röver S; Andjelkovic M; Bénardeau A; Chaput E; Guba W; Hebeisen P; Mohr S; Nettekoven M; Obst U; Richter WF; Ullmer C; Waldmeier P; Wright MB
J Med Chem; 2013 Dec; 56(24):9874-96. PubMed ID: 24175572
[TBL] [Abstract][Full Text] [Related]
53. The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model.
Wilkerson JL; Niphakis MJ; Grim TW; Mustafa MA; Abdullah RA; Poklis JL; Dewey WL; Akbarali H; Banks ML; Wise LE; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2016 Apr; 357(1):145-56. PubMed ID: 26791602
[TBL] [Abstract][Full Text] [Related]
54. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.
Zhang H; Lund DM; Ciccone HA; Staatz WD; Ibrahim MM; Largent-Milnes TM; Seltzman HH; Spigelman I; Vanderah TW
Pain; 2018 Sep; 159(9):1814-1823. PubMed ID: 29781960
[TBL] [Abstract][Full Text] [Related]
55. Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice.
Chen W; Shui F; Liu C; Zhou X; Li W; Zheng Z; Fu W; Wang L
Front Pharmacol; 2017; 8():707. PubMed ID: 29051736
[TBL] [Abstract][Full Text] [Related]
56. The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain: A Review.
Bagher AM
J Microsc Ultrastruct; 2022; 10(2):47-54. PubMed ID: 35832317
[TBL] [Abstract][Full Text] [Related]
57. Preclinical toxicity evaluation of JD5037, a peripherally restricted CB
Kale VP; Gibbs S; Taylor JA; Zmarowski A; Novak J; Patton K; Sparrow B; Gorospe J; Anand S; Cinar R; Kunos G; Chorvat RJ; Terse PS
Regul Toxicol Pharmacol; 2019 Dec; 109():104483. PubMed ID: 31580887
[TBL] [Abstract][Full Text] [Related]
58. Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain.
Sierra S; Gupta A; Gomes I; Fowkes M; Ram A; Bobeck EN; Devi LA
ACS Pharmacol Transl Sci; 2019 Aug; 2(4):219-229. PubMed ID: 31565698
[TBL] [Abstract][Full Text] [Related]
59. 6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB
Zhang YM; Greco MN; Macielag MJ; Teleha CA; DesJarlais RL; Tang Y; Ho G; Hou C; Chen C; Zhao S; Kauffman J; Camacho R; Qi J; Murray W; Demarest K; Leonard J
J Med Chem; 2018 Nov; 61(22):10276-10298. PubMed ID: 30339387
[TBL] [Abstract][Full Text] [Related]
60. Peripherally restricted cannabinoid and mu-opioid receptor agonists synergistically attenuate neuropathic mechanical hypersensitivity in mice.
Limerick G; Uniyal A; Ford N; He S; Grenald SA; Zhang C; Cui X; Sivanesan E; Dong X; Guan Y; Raja SN
Pain; 2024 May; ():. PubMed ID: 38815196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
